Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Cost-Effectiveness of Once-Weekly Semaglutide 1 mg versus Canagliflozin 300 mg in Patients with Type 2 Diabetes Mellitus in a Canadian Setting
PaperCitations, authors & open-access status
Cost-Effectiveness of Once-Weekly Semaglutide 1 mg versus Canagliflozin 300 mg in Patients with Type 2 Diabetes Mellitus in a Canadian Setting is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 10 citations, 2022 year and hybrid oa status.
10
Citations
2022
Year
hybrid
OA Status